You are on page 1of 3



 

Inclusion Criteria Confirmed uncomplicated DVT.

Over 13 years, suitable for adult dosing and not under the care of a Paediatrician.  If pregnant less than 22 weeks gestation. Client’s medical condition has been  assessed as stable, has a clear diagnosis and prognosis and is at a  low risk of rapid deterioration.
 

Exclusion Criteria Signs and symptoms suggestive of pulmonary embolus – refer to Clinical Protocol for Pulmonary Embolus CC-CP-006. Conditions that increase risk of bleeding including, recent major surgery, history of familial bleeding disorders, peptic ulcer disease, increased risk of falling, thrombocytopaenia. Uncontrolled Hypertension. High risk of thrombosis extension. Extensive DVT. Renal insufficiency – creatinine clearance below 30 mls/min) unless managed jointly with Haematologist or Thrombosis Clinic. Co-existing medical conditions requiring hospital admission. Known or suspected hypersensitivity to warfarin or enoxaparin (unless under governance of Haematology Consultant or Thrombosis Clinic at a tertiary centre.

ASSESSMENT 1 2 Check Target INR. Check Warfarin dose given to date (Marevan brand use without substitution unless continuation of current therapy). Weight. Current INR.

3 4

PATHOLOGY WORK UP Verify if any recent pathology has been ordered prior to requesting the below:

Baseline International Normalised Ratio (INR), Full Blood Picture (FBP), Liver Function Tests (LFT), Urea and Electrolytes (U&E) and Activated Partial Pro-thrombin Time (APTT). Thrombophilia screening thromboembolism. if familial history or recurrent/spontaneous venous

 

Calculation of creatinine clearance using Cockcroft – Gault equation. Day 5 - repeat full blood picture.
Review Date: 290512 Page 1 of 3


5 3. Elevate legs when sitting. Warfarin administered in collaboration with governing medical doctor. If a shorter time to therapeutic levels is indicated or for younger clients consider 7 to 10mg on day 1 and 2. Administer enoxoparin sodium as per medical authority (Dose 1.Clinical Protocol for Deep Vein Thrombosis (DVT) RECOMMENDED NOMOGRAM Day 1 2 and 3 4 and 5 INR 1.4 Below 1.9 2.5 – 4.6 – 3. Measure and fit anti-embolic stockings on affected limb. Nursing assessment as per Deep Vein Thrombosis (DVT) Assessment Tool.5 1.           CC-CP-007 Review Date: 290512 Page 2 of 3 .0 – 1.0 – 2.5 – 1.5mg/kg/SC given as single daily dose up to a maximum dose of 150mg.5 Above 4.8 Above 1. Consider smaller starting doses when the client is elderly.5 Suggested Dose 5mg 5mg 1mg 7mg 5mg 4mg 3mg 2mg Lab INR required 0mg Lab INR required This dosing regimen takes about 6 days to achieve therapeutic INR. If dose required is greater than 150mg dose must be given as divided doses twice daily and the dose is then 1mg/kg/SC – BD). has low body weight. INR to be monitored with coaguchek daily. Educate and advise client regarding warfarin including its potential complications and interactions as per Living with Warfarin booklet.5 a formal blood test required for confirmation). TREATMENT  Access blood results from referral source including thrombophillia screening if appropriate and scan results. longer in those under 60 years. Once INR 2 OR ABOVE continue to administer enoxoparin sodium for forty eight (48) hours to ensure target INR is maintained. (If reading  3.5 2.8 Below 1. Encourage gentle ambulation. Obtain last warfarin dose from referral source if not documented on referral form.

     REFERENCES Winter M. seven (7).au/online/view. Medical specialists may retain medical governance with treatment interventions delivered by Silver Chain.Tag West Australian Therapeutic advisory Group. Vallance P. American College of Emergency Physicians.(2010). Clin Lab Haem 2005. November 2008 [2009 Feb 24]. 429(10):124-135.rplibresources. eTG complete 2008. Living with Procedures for the outpatient management of patients with deep vein thrombosis. Available from: Australian Medicines 27:61-66. Cohen H. The diagnosis of deep vein thrombosis in symptomatic outpatients and the potential for clinical assessment and D-dimer assays to reduce the need for diagnostic imaging. CC-CP-007 Review Date: 290512 Page 3 of 3 .wa. days per week.rplibresources. Available from: British Society for [Online]. Fax protocol with client discharge summary to GP. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected lower extremity deep vein January 2009 [cited 2009 Feb 22]. Veroni M. Therapeutic Guidelines limited. [Online]. Keeling D. When governance is retained by a Silver Chain medical officer the client will have a medical review within twenty four (24) hours of admission and scheduled follow up as determined by the medical officer for that individual client.htm WA TAG Informaton for Patients. All Silver Chain medical officers are formally credentialed. medical officer/specialist holding medical governance and nursing staff.Explanatory Notes WA Anticoagulation Medication Chart WA. Care delivery is planned and provided in consultation with the client. In the instance when a client’s condition deteriorates the Silver Chain medical officer or nursing staff will confer with an emergency department medical officer.php?page=index. Br J Haem 2004.  MEDICAL GOVERNANCE  Client has access to medical governance support for twenty four (24) hours per day. Sharpens Silver Chain’s medical officer holding governance will determine when the client is discharged and a summary is sent to the referrer or the client’s GP. Ann Emerg Med 2003 Jul.amh. February Department of Health 2007.Clinical Protocol for Deep Vein Thrombosis (DVT) FOLLOW-UP  Ensure the client has an appointment arranged with own General Practitioner (GP) prior to discharge to ensure continuity of